Jump to content
African American Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

Search the Community

Showing results for tags ' pharmaceutical'.

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • African Americans Condition
    • General chat for African Americans
    • Opinions and News about the Discriminations and Maltreatments of the African Americans
    • Martin Luther King life
    • Malcolm X life
    • Barack Obama life
    • Michael Jeffrey Jordan life
    • Michael Jackson life
    • African American Celebrities
    • Is Racism Coming Back?
    • History of African Americans
    • Marriage and De facto Couples Interracial
    • Is the African American Community impoverishing?
    • Is the Government's Penal Policy Racist?
    • African American Dating
  • Opinions of the African Americans
    • Health Care and African Americans
    • Politics and African Americans
    • Religion and African Americans
    • Instruction and African Americans
    • Career and African Americans
    • Art and Artists for African Americans
    • Music for African Americans
    • Cinema for African Americans
    • Sports and African Americans
    • Television and African Americans
    • Books and African Americans
    • Cooking and African Americans
    • Games for African Americans
  • Presidency of Barack Obama's Brief history of Barack Obama's presidency

Blogs

  • Life of Martin Luther King Jr.
  • stefan will
  • Kevin Doe
  • Steffan Joe
  • Damon Salvatore
  • Michael Doe
  • Mason Joe

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


About Me

  1. To order this detailed 640+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html Key Inclusions § A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, location of headquarters and company size), clinical study sponsor(s) or collaborators, phase of development (clinical, preclinical, and discovery stage) of product candidates, type of molecule (small molecule and biologic), type of therapy (prebiotic,
  2. The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic has been officially approved by an authorized medical product regulator. However, the current development pipeline of microbiome therapeutics has several promising candidates that are likely to result in commercial success stories soon. To order this 640+ page report, which features 235+ fig
  3. Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings. To order this 640+ page report, which features 235+ figures and 275+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html Key Market Insights § Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the US has emerged as the major hub for microbiome-based research § The pipeline
  4. Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes: § A detailed assessment of the current market landscape of microbiome therapeutic
  5. Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings. The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture
  6. To order this detailed 235+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Key Inclusions § An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status of development, application area (abdomen, cardiac, gynecological, pulmonary, urological scanning and others), weight of device, type of transducer array (convex / curved, linear, micro-convex, transvaginal, phased and others), transducer frequency, mode of imaging (brightness, color doppler,
  7. According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19). To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/
  8. Roots Analysis has done a detailed study on “Global Handheld Ultrasound Imaging Devices Market, 2020-2030”” covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html Key Market Insights § Several players are currently engaged in the development / manufacturing of point-of-care handheld ultrasound scanners that offer a variety of imaging mo
  9. Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the unmet need in this domain. In fact, the demand for handheld ultrasound devices is on a surge amidst the COVID-19 pandemic. These portable, pocket-friendly, point-of-care devices have revolutionized the treatment of COVID-19 patients by provide remote access to doctors and ensures safety of the staff. Roots Analysis is pleased to announce the publication of its recent
  10. The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes Roots Analysis has announced the addition of “Global Handheld Ultrasound Imaging Devices Market, 2020-2030” report to its list of offerings. According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices
  11. To order this detailed 600+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html Key Inclusions § A detailed assessment of the current market landscape of ADCs, providing information on drug developer(s) and technology provider(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target antigen, type of linker, type of payload / warhead / cytotoxin, type of antibody, antibody origin, antibody isotype, type of therapy (monotherapy and co
  12. With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease associated cells / pathogens, with substantially lower risk of treatment related side effects. To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019
  13. Roots Analysis has done a detailed report on Antibody Drug Conjugates Market (5th Edition), 2019-2030.” , covering various important aspects of the industry and identifying key future growth opportunities. To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html Key Market Insights § Eminent representatives from different biopharmaceutical companies confirm the sustained interest in ADC therapeutics, highlighti
  14. Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth ana
  15. To order this detailed 320+ page report, please visit this - https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html Key Inclusions § A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals. It features information on the year of establishment, company size, purpose of production (fulfilling in-house requirements / for contract services), location of headquarters, location of manufacturing facilities, scale of production, applications
  16. The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers. To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this - https://www.rootsanalysi
  17. Roots Analysis has announced the addition of “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report to its list of offerings. To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this link Key Market Insights § Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise and supporting infrastructure to manufacture a wide variety of radioisotopes, for in-house use, or as a contract service § The market is fragmented, featuring the presence of companie
  18. The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” The report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radio
  19. To order this detailed 480+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html Key Inclusions § A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory), type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), r
  20. Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products. To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html T
  21. Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 480+ page report, which features 237 figures and 267 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html Key Market Insights § Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharm
  22. A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.” The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of
  23. To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html Key Inclusions § A detailed assessment of the current market landscape, including information on drug developer(s), § A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient recruitment (including pre-screening an
  24. A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographies and therapeutic indications. To order this 300+ page report, which features 90+ figure
  25. Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html Key Market Insights § Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to
×
  • Create New...